文献速递妇产影像技术与安全US

基于机器学习的孕早期母体特征与生物标志物预测子痫前期

Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

本研究基于英国两家产科医院11–13周前瞻性筛查数据,用人工神经网络结合母体特征与生物标志物预测子痫前期。早产型子痫前期在10%假阳性率下,仅母体因素检出率53.3%、AUC 0.816,加入生物标志物后升至75.3%、AUC 0.909;去除种族信息会降低预测准确性,尤其非白人人群。

要点

  • 早产型子痫前期预测加入生物标志物后10%假阳性率检出率由53.3%升至75.3%,AUC由0.816升至0.909。
  • 主要预测因子为高平均动脉压、高子宫动脉搏动指数和低胎盘生长因子。
  • 模型训练不使用种族信息时,仅母体因素筛查的早产型子痫前期检出率降至34.5–45.5%(不同种族)。

核心结论

  • 基于非线性机器学习方法筛查子痫前期不需要基于人群的标准化,其性能与逻辑回归相似。
  • 从模型中去除种族信息会降低预测准确性,尤其当仅考虑母体因素时的非白人人群。

研究设计与样本

  • 前瞻性非干预性筛查研究,数据来自英国两家产科医院11–13周妊娠期子痫前期筛查。
  • 数据分三部分:30437例用于训练,10000例用于优化机器学习超参数,20352例用于模型验证。
  • 采用人工神经网络,从人口学特征和病史预测先验风险,再结合生物标志物值确定子痫前期及37周前分娩的早产型子痫前期的风险。
  • 另训练一个不包含种族作为输入的神经网络;生物标志物包括子宫动脉搏动指数、平均动脉压、胎盘生长因子和妊娠相关血浆蛋白A,均使用原始值未转换为标准化中位数倍数。
  • 预测准确性用受试者工作特征曲线下面积(AUC)评估,并计算10%、20%和40%假阳性率下的检出率;还加入阿司匹林使用的影响,并用Shapley值评估各参数对风险预测的贡献。

诊断标准与关键数值

  • 早产型子痫前期 vs 无子痫前期:仅母体因素筛查在10%假阳性率下检出率53.3%、AUC 0.816;加入生物标志物后检出率75.3%、AUC 0.909。
  • 不使用种族信息训练模型时,仅母体因素筛查的早产型子痫前期 vs 无子痫前期在10%假阳性率下检出率降至34.5–45.5%(不同种族),加入生物标志物后为55.0–62.1%。
  • 全部子痫前期 vs 无子痫前期:仅母体因素筛查AUC 0.770、10%假阳性率下检出率41.3%;加入生物标志物后AUC 0.817、检出率52.9%。
  • 主要预测因子为高平均动脉压、高子宫动脉搏动指数和低胎盘生长因子。
  • 对早产型子痫前期高风险病例推荐使用阿司匹林。

临床应用与阅片要点

  • 孕早期11–13周筛查子痫前期时,在母体特征基础上加入子宫动脉搏动指数、平均动脉压、胎盘生长因子和妊娠相关血浆蛋白A可提高早产型子痫前期的预测准确性。
  • 模型使用原始生物标志物值而无需转换为中位数倍数,且机器学习方法性能与逻辑回归相似。
  • 训练模型时保留种族信息有助于维持预测准确性,尤其对非白人人群仅用母体因素筛查时。
  • 早产型子痫前期的预测准确性高于全部子痫前期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the accuracy of predicting the risk of developing pre-eclampsia (PE) according to first-trimester maternal demographic characteristics, medical history and biomarkers using artificial-intelligence and machine-learning methods.

METHODS: The data were derived from prospective non-interventional screening for PE at 11-13 weeks' gestation at two maternity hospitals in the UK. The data were divided into three subsets. The first set, including 30 437 subjects, was used to develop the training process, the second set of 10 000 subjects was utilized to optimize the machine-learning hyperparameters and the third set of 20 352 subjects was coded and used for model validation. An artificial neural network was used to predict from the demographic characteristics and medical history the prior risk that was then combined with biomarker values to determine the risk of PE and preterm PE with delivery at < 37 weeks' gestation. An additional network was trained without including race as input. Biomarkers included uterine artery pulsatility index (UtA-PI), mean arterial blood pressure (MAP), placental growth factor (PlGF) and pregnancy-associated plasma protein-A. All markers were entered using raw values without conversion into standardized multiples of the median. The prediction accuracy was estimated using the area under the receiver-operating-characteristics curve (AUC). We further computed the detection rate at 10%, 20% and 40% false-positive rates (FPR). The impact of taking aspirin was also added. Shapley values were calculated to evaluate the contribution of each parameter to the prediction of risk. We used a non-parametric test to compare the expected AUC with the one obtained when we randomly scrambled the labels and kept the predictions. For the general prediction, we performed 10 000 permutations of the labels. When the AUC was higher than the one obtained in all 10 000 permutations, we reported a P-value of < 0.0001. For the race-specific analysis, we performed 1000 permutations. When the AUC was higher than the AUC in permutations, we reported a P-value of < 0.001.

RESULTS: The detection rate for preterm PE vs no PE, at a 10% FPR, was 53.3% when screening by maternal factors only, and the corresponding AUC was 0.816; these increased to 75.3% and 0.909, respectively, with the addition of biomarkers into the model. Information on race was important for the prediction accuracy; when race was not used to train the model, at a 10% FPR, the detection rate of preterm PE vs no PE decreased to 34.5-45.5% (for different races) when screening by maternal factors only and to 55.0-62.1% when biomarkers were added. The major predictors of PE were high MAP and UtA-PI, and low PlGF. The accuracy of prediction of all PE cases was lower than that for preterm PE. Aspirin use was recommended for cases who were at high risk of preterm PE. The AUC of all PE vs no PE was 0.770 when screening by maternal factors and 0.817 when the biomarkers were added; the respective detection rates, at a 10% FPR, were 41.3% and 52.9%.

CONCLUSIONS: Screening for PE using a non-linear machine-learning-based approach does not require a population-based normalization, and its performance is similar to that of logistic regression. Removing race information from the model reduces its prediction accuracy, especially for the non-white populations when only maternal factors are considered. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ansbacher-Feldman Z, Syngelaki A, Meiri H, et al. Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers. Ultrasound Obstet Gynecol. 2022. PMID: 36454636. doi:10.1002/uog.26105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。